Concepedia

Publication | Open Access

Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know

DOIFull Paper Access

29

Citations

39

References

2017

Year

Pierre Delanaye, François Paquot, Antoine Bouquegneau, Frank Blocki, Jean-Marie Krzesinski, Pieter Evenepoel, Hans Pottel, Étienne Cavalier
Nephrology Dialysis Transplantation

Abstract

Clinical inference relating sclerostin levels found in the general, CKD and dialysis populations is largely influenced by the assay used to measure this biomarker.

References

YearCitations

Page 1